Väljaminev kiriAvalik
Vastus järelepärimisele
Ravimiamet · 19. august 2025
- Viit
- RST-1/4289-2
- Registreeritud
- 19. august 2025
- Dokumendi liik
- Väljaminev kiri
- Adressaat
- Sumitomo Seika
- Saabumis/saatmisviis
- Outlook
- Funktsioon
- RST Ravimistatistika tegemine
- Sari
- RST-1 Ravimistatistika alane kirjavahetus
- Toimik
- RST-1/2025
- Vastutaja
- Janne Sepp (RA, Peadirektori asetäitja valdkond, Ravimiohutuse osakond, Statistikabüroo)
Sisu (failidest)
Saatja: "Janne Sepp" <[email protected]>
Saaja: [email protected]
Teema: Vs: Data about Quetiapine and Etoricoxib
Kuupäev: 2025-07-29 10:15
Dear Alberto,
Thank you for your interest.
DDD/1000/day for N05AH04 and M01AH05 in 2024:
This data is available our website:
„Estonian Statistics on Medicines 2024“ (the data for all substances)
https://ravimiamet.ee/sites/default/files/documents/2025-04/DDD%202024%20ENG.pdf
Statistics on Medicines (general information)
https://ravimiamet.ee/en/statistics/statistics/statistics-medicines
Data for previous periods is available in our statistical yearbooks:
https://ravimiamet.ee/en/statistics/statistics/statistical-yearbooks
Kind regards,
Janne Sepp
State Agency of Medicines
Department of Post-Authorisation Safety
Bureau of Drug Statistics
Specialist
Phone: +372 737 4140
[email protected] <mailto:[email protected]>
Nooruse 1, 50411 Tartu, Estonia
www.ravimiamet.ee
This e-mail and any attachments transmitted may contain confidential and
privileged information. If you are not the intended recipient, please notify
the sender immediately by returning the e-mail and permanently deleting what
you have recieved. Any dissemination or use of this information by a third
person without permission is prohibited and may be illegaal.
From: アンジェル アルベルト ヌネズ マグロ <[email protected]
<mailto:[email protected]> >
Sent: Tuesday, July 29, 2025 8:51 AM
To: Ravimiamet <[email protected] <mailto:[email protected]> >
Cc: アンジェル アルベルト ヌネズ マグロ <[email protected]
<mailto:[email protected]> >
Subject: RE: Data about Quetiapine and Etoricoxib
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.
Dear Ravimiamet
My name is Alberto Nunez and I belong to sales department of gas and
chemical division in Sumitomo Seika Japan
I am looking for some data about the consumption (both amount and sales) of
the bellow medicines in Estonia
* Quetiapine (ATC: N05AH04)
* Etoricoxib (ATC: M01AH05)
I wonder if there is any source of raw data of medicine consumption in
Estonia. If so, would you please let me know how to access?
Thank you very much for your time
Alberto
_____
Dr Angel Alberto Núñez Magro Phd MBA Msc BEng.
Chemical and gas division
Sales manager
Sumitomo Seika
1-13-5 Kudan kita, Chiyoda-ku, Tokyo 102-0073
<Tel:+81-80-> Tel:+81-80-8318-1659
Linkedin: <https://www.linkedin.com/in/angelalbertonunezmagro/>
https://www.linkedin.com/in/angelalbertonunezmagro/
Mail: <mailto:[email protected]> [email protected]
_____